Nifty MidSmall Healthcare stocks list
NSESector30 companies
- P/EPrice to earnings of an index. The index's P/E as the exchange publishes it with the close: its members' market value divided by their profit over the last twelve months, each member counted as the index weighs it. Price to earnings of an index: how it is worked out
- 44.11
- P/BPrice to book of an index. The index's P/B as the exchange publishes it: its members' market value divided by their net worth, the assets they own less everything they owe.
- 5.28
- Dividend yieldDividend yield of an index. The index's dividend yield as the exchange publishes it: dividends its members paid over the last twelve months as a percentage of their market value.
- 0.38%
- 1MOne-month return of an index. The latest close against the close a month earlier, on the same date or the last trading day before it, as a percentage. One-month return of an index in the glossary
- −4.46%
- 3MThree-month return of an index. The latest close against the close three months earlier, on the same date or the last trading day before it, as a percentage. Three-month return of an index in the glossary
- −2.39%
- 1YOne-year return of an index. The latest close against the close a year earlier, on the same date or the last trading day before it, as a percentage. One-year return of an index in the glossary
- +13.75%
P/E against its own past
Where today's P/E sits among every trading day of each window: the dot is today, the tick the middle day.
At or below today's level on 50% of 1,048 trading days over the last 5 years.
At or below today's level on 30% of 743 trading days over the last 3 years.
At or below today's level on 64% of 247 trading days over the last 1 year.
P/E at each month's last trading day, and on 27 Oct 2026
What the Nifty MidSmall Healthcare companies earned
Revenue against the same quarter a year earlier, over today's members that filed both; profit after tax added up over the members that filed the quarter. A quarter fewer than 60% of them filed is left out, and the newest is added once nearly as many have filed it as the one before.
- Revenue growthRevenue growth, against a year earlier. Revenue of the quarter to Jun 2026 against the same quarter a year earlier, added up over the 30 companies that filed both.
- +18.8%quarter to Jun 2026
- ProfitProfit after tax, added up. Profit after tax of the quarter to Jun 2026, added up over the 30 companies that filed it; a loss counts as negative.
- ₹8,037 Crquarter to Jun 2026
- Filed the quarterCompanies that filed the quarter. How many of the index's 30 listed companies have filed results for the quarter to Jun 2026; the revenue growth and the profit are theirs.
- 30of 30
- Median ROCEMedian return on capital employed. The middle figure of the 30 companies' ROCE for the year to Mar 2026, half above and half below. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them.
- 13.0%year to Mar 2026
Revenue against the same quarter a year earlier, per cent
Profit after tax, ₹ crore, added up over the companies that filed
The largest companies
The 12 largest companies in the Nifty MidSmall Healthcare, each sized by its market cap.
Market cap, ₹ crore
- Laurus Labs₹1,15,735 Cr
- Mankind Pharma₹1,03,365 Cr
- Aurobindo Pharma₹93,643 Cr
- Lupin₹89,263 Cr
- Glenmark Pharmaceuticals₹63,944 Cr
- Alkem Laboratories₹60,715 Cr
- Aster DM Quality Care₹57,774 Cr
- Fortis Healthcare₹55,603 Cr
- Abbott India₹54,218 Cr
- Biocon₹54,179 Cr
- IPCA Laboratories₹50,254 Cr
- Gland Pharma₹48,848 Cr
Companies in the Nifty MidSmall Healthcare
Largest first, by market cap.Healthcare sector
Laurus LabsLAURUSLABS · Pharmaceuticals & Biotechnology₹2,142.00+4.04%₹1,15,735 Cr105.9019.8%0.09%+127.8%
Mankind PharmaMANKIND · Pharmaceuticals & Biotechnology₹2,502.50+8.24%₹1,03,365 Cr46.0013.6%None+3.6%
Aurobindo PharmaAUROPHARMA · Pharmaceuticals & Biotechnology₹1,627.50+2.36%₹93,643 Cr25.2011.5%None+48.7%
Glenmark PharmaceuticalsGLENMARK · Pharmaceuticals & Biotechnology₹2,265.70+1.79%₹63,944 Cr35.6039.8%0.11%+25.0%
Alkem LaboratoriesALKEM · Pharmaceuticals & Biotechnology₹5,078.00+0.95%₹60,715 Cr28.1016.5%1.04%−7.3%
Abbott IndiaABBOTINDIA · Pharmaceuticals & Biotechnology₹25,515.00+1.15%₹54,218 Cr33.6039.6%2.57%−14.3%
IPCA LaboratoriesIPCALAB · Pharmaceuticals & Biotechnology₹1,980.80+2.18%₹50,254 Cr38.4017.6%0.30%+52.6%
Anthem BiosciencesANTHEM · Pharmaceuticals & Biotechnology₹837.15+1.81%₹47,176 Cr81.9021.2%0.24%+14.5%
Ajanta PharmaAJANTPHARM · Pharmaceuticals & Biotechnology₹3,353.60−0.81%₹41,906 Cr36.9027.2%1.79%+40.1%
GlaxoSmithKline PharmaceuticalsGLAXO · Pharmaceuticals & Biotechnology₹2,472.40+1.08%₹41,884 Cr39.2056.3%2.31%−8.0%
Sai Life SciencesSAILIFE · Pharmaceuticals & Biotechnology₹1,486.20+2.83%₹31,570 Cr87.3018.7%None+69.2%
Acutaas ChemicalsACUTAAS · Pharmaceuticals & Biotechnology₹3,793.30+13.27%₹31,056 Cr70.7030.2%0.07%+119.1%
Krishna Institute of Medical SciencesKIMS · Healthcare Services₹697.65+4.19%₹29,302 Cr143.308.7%None−2.8%
Neuland LaboratoriesNEULANDLAB · Pharmaceuticals & Biotechnology₹19,315.00+1.36%₹24,781 Cr49.8032.1%0.18%+22.3%
Granules IndiaGRANULES · Pharmaceuticals & Biotechnology₹830.55+1.22%₹22,656 Cr34.2015.1%0.21%+46.8%
Cohance LifesciencesCOHANCE · Pharmaceuticals & Biotechnology₹479.25+3.39%₹18,336 Cr172.603.0%None−43.6%
Onesource Specialty PharmaONESOURCE · Pharmaceuticals & Biotechnology₹1,589.80+13.78%₹18,231 Cr–0.8%None−12.1%
Funds that follow the Nifty MidSmall Healthcare
3 index funds and ETFs track the Nifty MidSmall Healthcare.
Motilal Oswal Nifty Realty ETFETF · Motilal Oswal Mutual FundNAV₹80.84711Y−15.34%3Y–5Y–Size₹263 CrCost0.89%
Tata Nifty MidSmall Healthcare Index FundIndex Fund · Tata Mutual FundNAV₹14.70261Y+13.53%3Y–5Y–Size₹210 CrCost0.58%- Motilal Oswal Nifty MidSmall Healthcare Index FundIndex Fund · Motilal Oswal Mutual FundNAV₹12.08691Y+13.31%3Y–5Y–Size₹48 CrCost0.80%
About the Nifty MidSmall Healthcare
Nifty MidSmall Healthcare tracks the mid cap and small cap stocks within the healthcare sector. It includes up to 30 stocks, selected from the Nifty MidSmallcap 400, and is maintained by NSE Indices Limited.
How companies are chosen
Stocks in the Nifty MidSmallcap 400 at the time of review are eligible. A stock outside the futures and options segment that hit the circuit filter on at least 20% of trading days in the past 6 months is ineligible.
Eligible healthcare stocks are ranked by 6-month average free-float market capitalization (the market value of the shares normally available for trading, excluding promoter holdings), and 30 are selected. A stock not in the index joins only if its free-float market capitalization is at least 1.5 times that of the smallest constituent, which it replaces.
If fewer than 30 eligible stocks exist, the index continues with the number available.
How it is weighted
Each stock is weighted by its free float market capitalization. At rebalancing, no stock may exceed 33% and the top 3 stocks together may not exceed 62%, with capping applied on the last trading day of Mar, Jun, Sep and Dec.
When it is reviewed
The index is reconstituted semi-annually, in Mar and Sep along with the Nifty MidSmallcap 400, and rebalanced quarterly. The cut-off dates are 31 Jan and 31 Jul, using average data for six months. Changes are announced four weeks before they take effect.
Additional reconstitution and rebalancing happens if a constituent is excluded from the Nifty MidSmallcap 400 or is suspended, delisted or undergoes a scheme of arrangement.
Base date and value
The index has a base date of 1 Apr 2005 and a base value of 1000 points. It was launched on 3 Aug 2022.
- Published by
- NSE
- Kind
- Sector
- CompaniesCompanies in an index. How many companies the index holds on its current list, which the exchange revises from time to time. Companies in an index in the glossary
- 30
- List last changed
- 9 Oct 2026
- Above 200-day averageMembers above their 200-day average. The share of the index's members whose latest close is above their own average close of the last 200 trading days; members listed too recently to have one are left out. Members above their 200-day average in the glossary
- 18 of 30
Sector indices
Others in this group, the most used as a fund's benchmark first.All
- BSE Hospitals17 companiesP/E 59.59
BSE Power17 companiesP/E 27.98
BSE PSU Bank11 companiesP/E 7.12
Nifty Chemicals20 companiesP/E 39.84
Nifty Financial Services Ex-Bank30 companiesP/E 18.56
Nifty Oil & Gas15 companiesP/E 10.55
Nifty Pharma20 companiesP/E 41.20- Nifty REITs & Realty15 companiesP/E 51.48
- BSE BANKEX14 companiesP/E 12.18
BSE Financial Services197 companiesP/E 14.66